Audible Article by M. Valerie Lin, M.D., and Raymond Chung, M.D.

Recent FDA Approval of Sofosbuvir and Simeprevir. Implications for Current HCV Treatment

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Recent FDA Approval of Sofosbuvir and Simeprevir. Implications for Current HCV Treatment

Sign up to save your podcasts

Recent FDA Approval of Sofosbuvir and Simeprevir. Implications for Current HCV Treatment

Recent FDA Approval of Sofosbuvir and Simeprevir. Implications for Current HCV Treatment